Emtricitabine / Tenofovir Disoproxil Oral Tablet

DRUG5 trials

Sponsors

Public Health Foundation Enterprises, Inc., University of Chicago, Eastern Virginia Medical School

Conditions

Acceptability of Health CareAdherence, MedicationHIV PreventionHIV/AIDSPre-Exposure ProphylaxisRisk BehaviorTransgender Persons

Phase 2

Project Engage: Oral PrEP Acceptability

CompletedNCT05458765

Eastern Virginia Medical SchoolAcceptability of Health Care, Adherence, Medication

Start: 2022-06-21End: 2024-07-25Updated: 2024-07-29

Phase 4

The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community

CompletedNCT03120936

Public Health Foundation Enterprises, Inc.Pre-Exposure Prophylaxis, Transgender Persons

Start: 2017-08-08End: 2020-12-01Updated: 2021-04-21

DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence

CompletedNCT03387462

Public Health Foundation Enterprises, Inc.Adherence, Medication, HIV Prevention, Pre-Exposure Prophylaxis +1

Start: 2018-02-28End: 2018-08-30Updated: 2021-10-27

DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men

CompletedNCT03771638

Public Health Foundation Enterprises, Inc.Adherence, Medication, HIV Prevention, Pre-Exposure Prophylaxis +1

Start: 2019-02-01End: 2020-04-21Updated: 2025-07-03

Unknown Phase

Accelerated PrEP Access for Black MSM and TW

WithdrawnNCT04329442

University of ChicagoHIV/AIDS

Start: 2020-04-01End: 2021-07-31Updated: 2022-05-19

Related Papers

Acceptability of an automated directly observed therapy (DOT) application for PrEP adherence support among young men who have sex with men: a qualitative exploration

AIDS Care2024-09-021 citations

Randomized Controlled Trial of a Mobile Health Intervention to Promote Retention and Adherence to Preexposure Prophylaxis Among Young People at Risk for Human Immunodeficiency Virus: The EPIC Study

Clinical Infectious Diseases2018-09-13157 citations